Deferitazole

Drug Profile

Deferitazole

Alternative Names: Deferitazole magnesium; FBS-0701; SHP602; SPD-602; SSP-004184; SSP-004184AQ; SSP-004184SS

Latest Information Update: 04 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator FerroKin BioSciences
  • Class Heterocyclic acids; Small molecules; Thiazoles
  • Mechanism of Action Iron chelating agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Iron overload
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Iron overload

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 18 Mar 2014 Suspended - Phase-I for Iron overload in Australia (PO)
  • 18 Mar 2014 Suspended - Phase-II for Iron overload in USA, Canada, Italy, Lebanon, Thailand, Turkey and United Kingdom before March 2014 (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top